Correlation between GH and IGF-1 during treatment for acromegaly

Restricted access

OBJECTIVE

The relationship between growth hormone (GH) and insulin-like growth factor–1 (IGF-1) in patients with acromegaly as serial levels drop over time after treatment has not been examined previously. Knowledge of this relationship is important to correlate pretreatment levels that best predict response to treatment. To examine the correlation between GH and IGF-1 and IGF-1 z-scores over a wide range of GH levels, the authors examined serial GH and IGF-1 levels at intervals before and after surgery and radiosurgery for acromegaly.

METHODS

This retrospective analysis correlates 414 pairs of GH and IGF-1 values in 93 patients with acromegaly.

RESULTS

Absolute IGF-1 levels increase linearly with GH levels only up to a GH of 4 ng/ml, and with IGF-1 z-scores only to a GH level of 1 ng/ml. Between GH levels of 1 and 10 ng/ml, increases in IGF-1 z-scores relative to changes in GH diminish and then plateau at GH concentrations of about 10 ng/ml. From patient to patient there is a wide range of threshold GH levels beyond which IGF-1 increases are no longer linear, GH levels at which the IGF-1 response plateaus, IGF-1 levels at similar GH values after the IGF-1 response plateaus, and of IGF-1 levels at similar GH levels.

CONCLUSIONS

In acromegaly, although IGF-1 levels represent a combination of the integrated effects of GH secretion and GH action, the tumor produces GH, not IGF-1. Nonlinearity between GH and IGF-1 occurs at GH levels far below those previously recognized. To monitor tumor activity and tumor viability requires measurement of GH levels.

ABBREVIATIONS CV = coefficient of variation; GH = growth hormone; IGF-1 = insulin-like growth factor–1.
Article Information

Contributor Notes

INCLUDE WHEN CITING Published online November 18, 2016; DOI: 10.3171/2016.8.JNS161123.Correspondence Edward H. Oldfield, Department of Neurological Surgery, University of Virginia, Box 800212, Charlottesville, VA 22908. email: eho4u@virginia.edu.

© AANS, except where prohibited by US copyright law.

Headings
References
  • 1

    Abosch ATyrrell JBLamborn KRHannegan LTApplebury CBWilson CB: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:341134181998

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Bajuk Studen KBarkan A: Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling models. J Clin Endocrinol Metab 93:4914962008

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3

    Barkan ALBeitins IZKelch RP: Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67:69731988

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Barkan ALHalasz IDornfeld KJJaffe CAFriberg RDChandler WF: Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 82:318731911997

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Barkan ALStred SEReno KMarkovs MHopwood NJKelch RP: Increased growth hormone pulse frequency in acromegaly. J Clin Endocrinol Metab 69:122512331989

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Barrande GPittino-Lungo MCoste JPonvert DBertagna XLuton JP: Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85:377937852000

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7

    Bercu BBShulman DRoot AWSpiliotis BE: Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab 63:7097161986

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Bevan JSAtkin SLAtkinson ABBouloux PMHanna FHarris PE: Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab 87:455445632002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Bystrom CSheng SZhang KCaulfield MClarke NJReitz R: Clinical utility of insulin-like growth factor 1 and 2; determination by high resolution mass spectrometry. PLoS One 7:e434572012

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Bystrom CESheng SClarke NJ: Narrow mass extraction of time-of-flight data for quantitative analysis of proteins: determination of insulin-like growth factor-1. Anal Chem 83:900590102011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Castinetti FTaieb DKuhn JMChanson PTamura MJaquet P: Outcome of Gamma Knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90:448344882005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Chanson PArnoux AMavromati MBrailly-Tabard SMassart CYoung J: Reference values for insulin-like growth factor I (IGF-I) serum concentrations: comparison of six immunoassays. J Clin Endocrinol Metab 101:345034582016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Clemmons DRVan Wyk JJRidgway ECKliman BKjellberg RNUnderwood LE: Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 301:113811421979

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Colao AAttanasio RPivonello RCappabianca PCavallo LMLasio G: Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91:85922006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Eastman RCGorden PRoth J: Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab 48:9319401979

  • 16

    Elmlinger MWKühnel WWeber MMRanke MB: Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 42:6546642004

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Giusti MGussoni GCuttica CMGiordano G: Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. J Clin Endocrinol Metab 81:208920971996

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Hartman MLPincus SMJohnson MLMatthews DHFaunt LMVance ML: Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94:127712881994

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Hartman MLVeldhuis JDVance MLFaria ACFurlanetto RWThorner MO: Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab 70:137513841990

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Holdaway IMRajasoorya RCGamble GD: Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:6676742004

  • 21

    Jane JA JrStarke RMElzoghby MAReames DLPayne SCThorner MO: Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96:273227402011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Jenkins PJBates PCarson MNStewart PMWass JAH: Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91:123912452006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Kaltsas GAIsidori AMFlorakis DTrainer PJCamacho-Hubner CAfshar F: Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86:164516522001

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Lamberts SWUitterlinden PVerleun T: Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with sandostatin (SMS 201-995). Eur J Clin Invest 17:3543591987

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Landolt AMHaller DLomax NScheib SSchubiger OSiegfried J: Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85:128712892000

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Lee CCVance MLXu ZYen CPSchlesinger DDodson B: Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab 99:127312812014

  • 27

    Losa MGioia LPicozzi PFranzin AValle MGiovanelli M: The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93:254625522008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Newman CBMelmed SSnyder PJYoung WFBoyajy LDLevy R: Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients—a clinical research center study. J Clin Endocrinol Metab 80:276827751995

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Nomikos PBuchfelder MFahlbusch R: The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol 152:3793872005

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    Peacey SRToogood AAVeldhuis JDThorner MOShalet SM: The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. J Clin Endocrinol Metab 86:2592662001

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Petrossians PBorges-Martins LEspinoza CDaly ABetea DValdes-Socin H: Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur J Endocrinol 152:61662005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Roelfsema FBiermasz NRPereira AMVeldhuis JD: Optimizing blood sampling protocols in patients with acromegaly for the estimation of growth hormone secretion. J Clin Endocrinol Metab 101:267526822016

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Schwyzer LStarke RMJane JA JrOldfield EH: Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly. J Neurosurg 122:7988022015

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Semer MFaria ACNery MSalgado LRKnoepfelmacher MWajchenberg BL: Growth hormone pulsatility in active and cured acromegalic subjects. J Clin Endocrinol Metab 80:376737701995

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Sheaves RJenkins PBlackburn PHuneidi AHAfshar FMedbak S: Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 45:4074131996

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Shimon ICohen ZRRam ZHadani M: Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48:123912452001

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Starke RMRaper DMSPayne SCVance MLOldfield EHJane JA Jr: Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:319031982013

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    Swearingen BBarker FG IIKatznelson LBiller BMGrinspoon SKlibanski A: Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:341934261998

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    van den Berg GFrölich MVeldhuis JDRoelfsema F: Growth hormone secretion in recently operated acromegalic patients. J Clin Endocrinol Metab 79:170617151994

    • Search Google Scholar
    • Export Citation
  • 40

    van der Klaauw AAPereira AMvan Thiel SWFrolich MIranmanesh AVeldhuis JD: Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. Clin Endocrinol (Oxf) 66:4894982007

    • Search Google Scholar
    • Export Citation
  • 41

    van der Lely AJde Herder WWLamberts SW: The role of radiotherapy in acromegaly. J Clin Endocrinol Metab 82:318531861997

TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 411 410 45
Full Text Views 527 413 3
PDF Downloads 490 341 2
EPUB Downloads 0 0 0
PubMed
Google Scholar